Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
Neurosurgery|September 12, 2000
An integrated functional magnetic resonance imaging procedure for preoperative mapping of cortical areas associated with tactile, motor, language, and visual functionsJ Hirsch, M I Ruge, K H Kim, et al.European Journal of Haematology|November 12, 2022
Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC-Dutch late effects cohort-linked dataSidsel Jacobsen Juul, Michal Kicinski, Michael Schaapveld, et al.Clinical Radiology|January 23, 2021
Personalising sarcoma care using quantitative multimodality imaging for response assessmentG M Kalisvaart, J L Bloem, J V M G Bovée, et al.International Journal of Radiation Oncology, Biology, Physics|September 9, 2014
Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivorsLaurien A Daniëls, Stijn D G Krol, Michiel A de Graaf, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1996
High-dose edatrexate with oral leucovorin rescue: a phase I and clinical pharmacological study in adults with advanced cancerK M Pisters, L B Tyson, W Tong, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin LymphomaFrederika A van Nimwegen, Michael Schaapveld, David J Cutter, et al.Scientific Reports|May 20, 2017
Somatic Tumor Mutations Detected by Targeted Next Generation Sequencing in Minute Amounts of Serum-Derived Cell-Free DNAMarjolein J A Weerts, Ronald van Marion, Jean C A Helmijr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 10, 2022
Development and Validation of Risk Prediction Models for Coronary Heart Disease and Heart Failure After Treatment for Hodgkin LymphomaSimone de Vries, Miriam L Haaksma, Katarzyna Jóźwiak, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2021
Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: Feasibility and need for plan adaptationMichiel Kroesen, Vesna Miladinovic, Stefan A J Hutschemaekers, et al.Blood|April 18, 2014
Risk of multiple primary malignancies following treatment of Hodgkin lymphomaAnna M van Eggermond, Michael Schaapveld, Pieternella J Lugtenburg, et al.Pageof 20